These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7507054)

  • 21. Proliferation of Prostate Stromal Cell Induced by Benign Prostatic Hyperplasia Epithelial Cell Stimulated With Trichomonas vaginalis via Crosstalk With Mast Cell.
    Kim JH; Kim SS; Han IH; Sim S; Ahn MH; Ryu JS
    Prostate; 2016 Nov; 76(15):1431-44. PubMed ID: 27325623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign prostatic hyperplasia and growth factors.
    Lawson RK
    Urologe A; 1990 Jan; 29(1):5-7. PubMed ID: 1690485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathology of benign prostatic hyperplasia. Insight into etiology.
    McNeal J
    Urol Clin North Am; 1990 Aug; 17(3):477-86. PubMed ID: 1695776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Physiopathological aspects of the treatment of benign prostatic hypertrophy. Role of prostatic stroma and estrogens].
    Solè-Balcells F
    J Urol (Paris); 1993; 99(6):303-6. PubMed ID: 7516373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The origin and development of benign prostatic hyperplasia. An age-dependent process.
    Oesterling JE
    J Androl; 1991; 12(6):348-55. PubMed ID: 1722790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etiology of benign prostatic hyperplasia.
    Isaacs JT
    Eur Urol; 1994; 25 Suppl 1():6-9. PubMed ID: 7507055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathology of BPH.
    Di Silverio F; D'Eramo G; Flammia GP; Caponera M; Frascaro E; Buscarini M; Mariani M; Sciarra A
    Minerva Urol Nefrol; 1993 Dec; 45(4):135-42. PubMed ID: 7517581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia.
    Wang L; Xie L; Tintani F; Xie H; Li C; Cui Z; Wan M; Zu X; Qi L; Cao X
    Stem Cells Transl Med; 2017 Feb; 6(2):394-404. PubMed ID: 28191756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Functional morphology of the prostate].
    Aumüller G
    Urologe A; 1989 Nov; 28(6):306-10. PubMed ID: 2481355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxytocin: its role in benign prostatic hyperplasia via the ERK pathway.
    Xu H; Fu S; Chen Y; Chen Q; Gu M; Liu C; Qiao Z; Zhou J; Wang Z
    Clin Sci (Lond); 2017 Apr; 131(7):595-607. PubMed ID: 28130436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in prostatic stromal composition and benign prostatic hyperplasia].
    Shen W; Mao XM; Lü J; Yao HQ; Deng ZX; Zhao YB; Liu J; Hua W; Wang BQ; Hu WL
    Zhonghua Nan Ke Xue; 2011 Aug; 17(8):703-6. PubMed ID: 21898992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of biochemical (receptors, endogenous tissue hormones) and quantitative morphologic (stereologic) findings in normal and hyperplastic human prostates.
    Bartsch G; Keen F; Daxenbichler G; Marth C; Margreiter R; Brüngger A; Sutter T; Rohr HP
    J Urol; 1987 Mar; 137(3):559-64. PubMed ID: 2434669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proliferation of prostate epithelia induced by IL-6 from stroma reacted with Trichomonas vaginalis.
    Kim JH; Han IH; Kim YS; Noh CS; Ryu JS
    Parasite Immunol; 2018 Jun; 40(6):e12531. PubMed ID: 29633291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of long-term administration of androgens and estrogen on rhesus monkey prostate: possible induction of benign prostatic hyperplasia.
    Jeyaraj DA; Udayakumar TS; Rajalakshmi M; Pal PC; Sharma RS
    J Androl; 2000; 21(6):833-41. PubMed ID: 11105909
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Light-microscopic stereologic analysis of spontaneous and steroid-induced canine prostatic hyperplasia.
    Bartsch G; Bruengger A; de Klerk DP; Coffey DS; Rohr HP
    J Urol; 1987 Mar; 137(3):552-8. PubMed ID: 2434668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benign prostatic hyperplasia: a review of its histogenesis and natural history.
    Oesterling JE
    Prostate Suppl; 1996; 6():67-73. PubMed ID: 8630233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-18 may lead to benign prostatic hyperplasia via thrombospondin-1 production in prostatic smooth muscle cells.
    Hamakawa T; Sasaki S; Shibata Y; Imura M; Kubota Y; Kojima Y; Kohri K
    Prostate; 2014 May; 74(6):590-601. PubMed ID: 24615654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 4. Steroid pathophysiology of BPH. Correlative morphological and biochemical investigations on the stromal tissue of the human prostate.
    Bartsch G; Daxenbichler G; Rohr HP
    J Steroid Biochem; 1983 Jul; 19(1A):147-54. PubMed ID: 6193337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered FGF-2 expression induces glandular epithelial hyperplasia in the murine prostatic dorsal lobe.
    Konno-Takahashi N; Takeuchi T; Nishimatsu H; Kamijo T; Tomita K; Schalken JA; Teshima S; Kitamura T
    Eur Urol; 2004 Jul; 46(1):126-32. PubMed ID: 15183558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.